The number of people with susceptibility test result for rifampicin in Bangladesh
Bangladesh: The number of people with susceptibility test result for rifampicin was 82,924 in 2021. ▲ Rising
Latest (2021)
82,924
Change on year
up 73.2%
World rank
7th
of 155 countries
All-time high
82,924
in 2021
All-time low
36,583
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bangladesh, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Bangladesh stood at 82,924. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 73.2% on the previous year and up 112.8% over five years.
Bangladesh ranks 7th of 155 countries on this measure, in the top 10%.
The number of people with susceptibility test result for rifampicin in Bangladesh, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 38,977 | — |
| 2018 | 36,583 | -6.1% |
| 2019 | 42,461 | +16.1% |
| 2020 | 47,877 | +12.8% |
| 2021 | 82,924 | +73.2% |
Bangladesh compared with similar countries
- Bangladesh's 82,924 is above the median for lower middle income countries, which is 2,804, 29.6× the median. (32 countries reporting)
- Bangladesh's 82,924 is above the median for South Asia, which is 11,863, 7.0× the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 39,340 | 36,583 | 42,461 | 3 |
| 2020s | 65,400 | 47,877 | 82,924 | 2 |
Countries ranked near Bangladesh
More health data for Bangladesh
- Un projection of annual infant deaths, annual growth rate -2.36 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,153 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,062 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 35 (2025)
- Population ages 00-04, female, annual growth rate 0.8772 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0468 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7714 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bangladesh?
- The number of people with susceptibility test result for rifampicin in Bangladesh was 82,924 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bangladesh?
- The highest recorded value was 82,924 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bangladesh?
- The lowest recorded value was 36,583 in 2018.
- How does Bangladesh rank for the number of people with susceptibility test result for rifampicin?
- Bangladesh ranks 7th out of 155 countries with data for 2021.
- Where does this Bangladesh data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).